Michel Blanc

Michel Blanc did study organic chemistry and chemical engineering at Ecole Centrale de Marseille in France. He brings over 18 years of experience in servicing Pharmaceutical companies. He held global Business Development responsibilities and was part of the management team at well established Drug Substance and Drug Product CDMOs or APIs producers (Avecia (now part of Piramal), NextPharma, Novasep, Seqens or Pharmazell).

Michel was also a board member of the French fine chemical industry association (SICOS Biochimie) and of the French CDMO association (SPIS now CDMO France).